{"Title": "Individual patient risk assessment and cost\u2013benefit analysis of patiromer in AMBER \u2013 Authors' reply", "Year": 2020, "Source": "Lancet", "Volume": "396", "Issue": 10247, "Art.No": null, "PageStart": 311, "PageEnd": 312, "CitedBy": 0, "DOI": "10.1016/S0140-6736(20)30534-1", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088840802&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Amber", "Cost-Benefit Analysis", "Humans", "Hyperkalemia", "Polymers", "Risk Assessment"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 1, "EID": "2-s2.0-85088840802", "SubjectAreas": [["Medicine (all)", "MEDI", "2700"]], "AuthorData": {"55200022600": {"Name": "Agarwal R.", "AuthorID": "55200022600", "AffiliationID": "60021947", "AffiliationName": "Department of Medicine, Division of Nephrology, Indiana University School of Medicine"}, "7006015976": {"Name": "Rossignol P.", "AuthorID": "7006015976", "AffiliationID": "60104289, 60105521, 60138560, 60000905, 60020606", "AffiliationName": "University of Lorraine, Inserm 1433, Centre d'investigation Clinique Plurith\u00e9matique Centre Hospitalier R\u00e9gional Universitaire de Nancy, Inserm U1116 and French Clinical Research Infrastructure Network Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists"}, "36047547400": {"Name": "White W.B.", "AuthorID": "36047547400", "AffiliationID": "60000948, 60000209", "AffiliationName": "Calhoun Cardiology Center, University of Connecticut School of Medicine"}, "57198065489": {"Name": "Williams B.", "AuthorID": "57198065489", "AffiliationID": "60024544, 60022148, 60172638", "AffiliationName": "National Institute for Health Research, University College London and University College London Hospitals Biomedical Research Centre"}}}